# A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects

> **NCT02622685** · PHASE1 · COMPLETED · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 58 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** DWP10292
- **DRUG:** DWP10292 Placebo
- **DRUG:** Ursodeoxycholic acid (UDCA)
- **DRUG:** UDCA Placebo

## Key facts

- **NCT ID:** NCT02622685
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2016-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02622685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02622685, "A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02622685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*